Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Schnetzer

Orthopaedic Surgery Macon, GA Medical Doctor

NPI 1013236348 CMS profile 734173

3708 Northside Dr, Macon, GA 31210

Open in the dashboard

General payments

$103,532

250 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Schnetzer of Macon, GA is reported in the CMS Open Payments database as having received $103,532 across 250 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $26,721 35
2024 General $21,119 47
2023 General $26,267 46
2022 General $11,103 35
2021 General $7,267 36
2020 General $7,841 21
2019 General $3,213 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Schnetzer
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Ryan Schnetzer were reported at $26,721. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Ryan Schnetzer Orthopaedic Surgery median Middle half National median
2019 $3,213 $644 $140–$2,844 $163
2020 $7,841 $312 $75–$1,860 $114
2021 $7,267 $520 $117–$2,495 $132
2022 $11,103 $598 $128–$2,731 $149
2023 $26,267 $461 $128–$2,264 $160
2024 $21,119 $497 $134–$2,475 $164
2025 $26,721 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $74,289 176 payments
  2. VB Spine LLC $17,908 6 payments
  3. Choice Spine, LLC $6,778 2 payments
  4. SI-BONE, Inc. $2,615 12 payments
  5. Boston Scientific Corporation $557 15 payments
  6. Medtronic, Inc. $177 2 payments
  7. DePuy Synthes Sales Inc. $143 6 payments
  8. Encore Medical, LP $142 1 payment
  9. Medtronic USA, Inc. $101 3 payments
  10. Baxter Healthcare $95 3 payments
  11. Other $728 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $83,444 20 payments
  2. Food and Beverage $10,382 194 payments
  3. Travel and Lodging $9,706 36 payments
Products named General payments · program years 2019–2025
  1. CASCADIA INTERBODY SYSTEM Spine $16,413 16 payments
  2. NIAGARA LATERAL ACCESS SYSTEM $13,000 3 payments
  3. CORE $11,116 5 payments
  4. EVEREST SPINAL SYSTEM $10,035 16 payments
  5. CASCADIA INTERBODY SYSTEM Spine $8,500 1 payment
  6. CAPRI CORPECTOMY CAGE SYSTEM $7,795 5 payments
  7. MESA SPINAL SYSTEM $7,612 5 payments
  8. OZARK CERVICAL PLATE SYSTEM Spine $7,500 1 payment
  9. ALEUTIAN CERVICAL $7,500 1 payment
  10. OZARK CERVICAL PLATE SYSTEM Spine $7,500 1 payment
  11. Other $41,745 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

783

Median for Orthopedic Surgery: 203

Drug cost

$4,016

Median for Orthopedic Surgery: $1,433

Branded share of claims

14.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 163 $1,349
Cyclobenzaprine Hcl Generic 105 $737
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 57 $469
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $341
Tizanidine Hcl Generic 44 $340
Meloxicam Generic 105 $271
Tramadol Hcl Generic 66 $164
Diazepam Generic 172 $144
Acetaminophen-Codeine Acetaminophen With Codeine Brand 16 $117
Methylprednisolone Generic 14 $86

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$163,521

Of which drugs: $1,331

Medicare patients

458

Average age 73

Services billed

1,947

258 women, 200 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 40%
Chronic kidney disease 39%
Ischemic heart disease 30%
Depression 25%
Atrial fibrillation 20%
Cancer 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

250 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record